Sunshine Biopharma Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 48.4% | -1,068.2% | -5,444.4% |
| FY2022 | 39.0% | -621.3% | -615.4% |
| FY2023 | 34.6% | -19.9% | -18.7% |
| FY2024 | 30.6% | -16.7% | -14.7% |
| FY2025 | 33.8% | -17.2% | -16.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 48.4% | -1,068.2% | -5,444.4% |
| FY2022 | 39.0% | -621.3% | -615.4% |
| FY2023 | 34.6% | -19.9% | -18.7% |
| FY2024 | 30.6% | -16.7% | -14.7% |
| FY2025 | 33.8% | -17.2% | -16.5% |